• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Medisafe Launches “Medisafe Insights” to Turn Medication Data Into Actionable Insights for Pharma

by Fred Pennic 08/14/2017 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Medisafe Launches “Medisafe Insights” for Real-Time Patient Behavioral Trends Impacting Medication Management

Medisafe, a personalized medication management platform has announced the launch of Medisafe Insights, a proprietary market research tool (HIPAA compliant and ISO secure) for pharma. Eclipsing 4 million users and 1 billion doses managed, Medisafe is turning its database of patient information, combining demographics, medication details, medical conditions and comorbidities, engagement with content and interventions, and other key information, into actionable insights for pharma. The launch of Medisafe Insights comes one year after announcing its commercial offering for pharma and life sciences companies and launching several successful pilot programs.

With Medisafe Insights, pharmaceutical and life sciences companies can:

· Discover new details about patient personas based on real-time data linked to their medication behavior, in a de-identified manner

· Identify patient cohort-specific adherence obstacles throughout the patient journey

· Learn new approaches and tactics to more effectively target and engage patients and improve their adherence and persistence

· Benchmark their brand against the competition

· Translate these key learnings into greater revenues and market share

Pharma has a data problem. Until now, pharma has faced the issue of medication non-adherence without the necessary information, at scale, required to solve this multi-hundred billion dollar problem. With Medisafe Insights, access to this level of real-time de-identified behavioral data at the medication dose level will be a game changer for pharma considering the traditional instruments that pharma has used are lagged and far less precise because they rely on monthly medication refill records.

The causes of nonadherence vary by medication, condition, patient and specific timeframe across the patient journey, negatively impacting patient quality of care and health outcomes (e.g. higher emergency and mortality rates), healthcare system costs (e.g. higher hospitalization rates) and pharma and pharmacy revenues (e.g. fewer prescription refills). Lost revenues to pharma are estimated at $188 billion annually in the U.S. and $637 billion globally.

“To address a problem as big as medication non-adherence, that costs the healthcare system hundreds of billions of dollars, pharma must have the best data and solutions to effectively solve this problem in a personalized way. Until now, pharma lacked access to patient focused insights, at scale, required to have a complete understanding of the problem,” said Omri Shor, co-founder and CEO in a statement. “As a market leader, Medisafe is well positioned to offer a unique view into patients’ lives and how surrounding circumstances impact their ability to take their medications as prescribed. We believe these insights, joined with our unique ability to respond in real-time and offer tailored solutions, will not only have a profound impact on patient health outcomes, but also support the pharmaceutical industry as we address the wider issue of non-adherence.”

Pricing

Medisafe Insights can be purchased on a one-time starting at $999 per survey or ongoing basis.  In addition, an Insights package can be coupled with a Medisafe license, which enables pharma brands to engage Medisafe users directly and put their learnings into action with near-term benefits of increased medication adherence, persistence and revenues. Introductory pricing is now available through mid-September 2017.

 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Medication Adherence, Medisafe

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance

Most-Read

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

CB Insights’ 2026 Digital Health 50 Reveals How Agentic AI Is Becoming the Clinical Provider and Medication Access Engine

Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

M&A: Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

CVS Rebrands Health Services Segment, Launches Model for Retail Pharmacy Reimbursement

CVS Health Formalizes Tax-Free Split-Off to Carve Out CVS Pharmacy by 2028

SAMHSA and ONC Invest $20M in Behavioral Health IT Initiative

ONC Finalizes HTI-5 Deregulatory Rule to Cut $1.55B in Health IT Compliance and Accelerate FHIR APIs

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |